Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Zhong Ji Longevity Science Group Limited ( (HK:0767) ) has provided an announcement.
Zhong Ji Longevity Science Group Limited announced the resignation of Mr. Yan Yifan and Ms. Cao Xie Qiong from their executive director roles, with Mr. Yan also stepping down as CEO to focus on personal commitments. Mr. Yan Li, an experienced executive in the medical technology field and already serving as the company’s chairman, has been appointed as the new CEO. This leadership change may impact the company’s strategic direction and operational focus, as Mr. Yan Li brings significant expertise in biotechnology and management.
More about Zhong Ji Longevity Science Group Limited
Zhong Ji Longevity Science Group Limited operates in the advanced medical and biological technology industry, focusing on cell testing, storage, enhancement, and gene therapies. The company aims to establish a leading international medical transformation platform and is involved in the research, development, and sale of biotechnology products.
Average Trading Volume: 998,025
Technical Sentiment Signal: Hold
Current Market Cap: HK$356.5M
Learn more about 0767 stock on TipRanks’ Stock Analysis page.